These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8623202)

  • 1. In support of the findings of Christopher F. Bryan et al.
    Fuller TC; Fuller A; McCormack JM; Rodey GE
    Transplantation; 1996 Apr; 61(7):1127-9. PubMed ID: 8623202
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss.
    Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J
    Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368
    [No Abstract]   [Full Text] [Related]  

  • 3. Lung transplantation under a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen results in low titers of HLA and MICA IgG antibodies which are not related to development of BOS.
    Paantjens AW; van de Graaf EA; van Ginkel WG; van den Bosch JM; Otten HG
    J Heart Lung Transplant; 2010 May; 29(5):596-8. PubMed ID: 20207170
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry crossmatching: a method for monitoring antidonor antibodies in heart transplant recipients.
    Hurley JP; Cook DJ; McCarthy PM; Hobbs RE; Koo AP; Ratliff NB; Klingman LL; Mrzena K; Stewart RW
    Transplant Proc; 1995 Feb; 27(1):1301-2. PubMed ID: 7878891
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of alloimmunized, refractory patients in need of platelet transfusions.
    Engelfriet CP; Reesink HW; Aster RH; Brand A; Tomson B; Claas FH; Contreras M; Navarrete C; Jørgensen J; Murphy MF; Curtis R; Waters AH; Panzer S; Kurz M; Höcker P; Mayr WR; Schiffer CA
    Vox Sang; 1997; 73(3):191-8. PubMed ID: 9358625
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of ELISA and Luminex panel reactive antibody assays for HLA alloantibody screening].
    Jung S; Oh EJ; Yang CW; Ahn WS; Kim Y; Park YJ; Han K
    Korean J Lab Med; 2009 Oct; 29(5):473-80. PubMed ID: 19893358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HLA and MICA antibodies before kidney graft failure.
    Mizutani K; Shibata L; Ozawa M; Esquenazi V; Rosen A; Miller J; Terasaki PI
    Clin Transpl; 2006; ():255-64. PubMed ID: 18365383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous immunoglobulin in sensitized LVAD recipients.
    Dowling RD; Jones JW; Carroll MS; Gray LA
    Transplant Proc; 1998 Jun; 30(4):1110-1. PubMed ID: 9636450
    [No Abstract]   [Full Text] [Related]  

  • 10. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of posttransplant HLA class I and class II antibodies on renal graft outcome.
    Piazza A; Poggi E; Borrelli L; Valeri M; Buonomo O; Servetti S; Adorno D; Casciani CU
    Transplant Proc; 2001; 33(1-2):478-80. PubMed ID: 11266917
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of HLA-class I alloantibodies using PRA-STAT and complement-dependent cytotoxicity techniques.
    Papassavas AC; Iniotaki-Theodoraki A; Stathakopoulou A; Ioannou S; Kostakis A; Stavropoulos-Giokas C
    Transplant Proc; 1998 May; 30(3):724-6. PubMed ID: 9595073
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
    Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
    Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantigen-blocking antibodies in sera from highly sensitized uremic patients: antibody class and relationship with lymphocytotoxins.
    Shoker AS; Okasha K; Sheridan DP; Kappel JE; Baltzan MA
    Transplantation; 1997 Sep; 64(6):853-60. PubMed ID: 9326410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-donor antibodies in allogeneic cornea transplantation.
    Zavazava N; Duncker G; Jenisch S; Nölle B; Westphal E; Müller-Ruchholtz W
    Transplant Proc; 1995 Feb; 27(1):1410-1. PubMed ID: 7878928
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responses.
    Leith JG; Clark DA; Matthews TJ; Rosenthal KL; Luscher MA; Barber BH; MacDonald KS
    AIDS Res Hum Retroviruses; 2003 Nov; 19(11):957-65. PubMed ID: 14678602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-matched blood transfusions?
    Scornik JC
    Transplantation; 2012 Dec; 94(11):1085. PubMed ID: 23111497
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitization to HLA antigens in islet recipients with failing transplants.
    Olack BJ; Swanson CJ; Flavin KS; Phelan D; Brennan DC; White NH; Lacy PE; Scharp DW; Poindexter N; Mohanakumar T
    Transplant Proc; 1997 Jun; 29(4):2268-9. PubMed ID: 9193621
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection and specification of noncomplement binding anti-HLA alloantibodies.
    Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
    Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.